Description
Topiramate is an antiepilepsy drug.
Indications
– Monotherapy in adults, adolescents and children over 6 years of age with partial seizures with or without secondary generalised seizures, and primary generalised tonic-clonic seizures.
– Adjunctive therapy in children aged 2 years and above, adolescents and adults with partial onset seizures with or without secondary generalization or primary generalized tonic-clonic seizures and for the treatment of seizures associated with Lennox-Gastaut syndrome.
– Topiramate is indicated in adults for the prophylaxis of migraine headache after careful evaluation of possible alternative treatment options and is not intended for acute treatment.
Subject to medical prescription
Pharmaceutical form: 50 mg x 30 film-coated tablets
NHIF code: NF 675 ICD: G40.6, G40.7
Pharmaceutical form: 100 mg x 30 film-coated tablets
NHIF code: NF 676 ICD: G40.6, G40.7
